[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Danaher Corp (DHR)

Danaher Corp (DHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Revvity Stock Underperforming the Nasdaq?

Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $11.2 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and RVTY perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the diagnostics & research industry. Revvity’s strengths include diversification, scale, cross-business synergies, brand equity, financial resilience, and technological capabilities. These strengths enable the company to...

Fundamentals

See More
  • Market Capitalization, $K 125,395,792
  • Shares Outstanding, K 707,771
  • Annual Sales, $ 24,568 M
  • Annual Income, $ 3,614 M
  • EBIT $ 4,760 M
  • EBITDA $ 7,207 M
  • 60-Month Beta 0.81
  • Price/Sales 5.12
  • Price/Cash Flow 15.64
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 30.64% (+0.02%)
  • Historical Volatility 29.40%
  • IV Percentile 59%
  • IV Rank 46.79%
  • IV High 40.44% on 10/01/25
  • IV Low 22.02% on 12/24/25
  • Expected Move (DTE 6) 5.53 (3.12%)
  • Put/Call Vol Ratio 0.39
  • Today's Volume 5,134
  • Volume Avg (30-Day) 4,980
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 90,119
  • Open Int (30-Day) 84,068
  • Expected Range 171.65 to 182.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.84
  • Number of Estimates 9
  • High Estimate $1.90
  • Low Estimate $1.83
  • Prior Year $1.80
  • Growth Rate Est. (year over year) +2.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
164.07 +7.98%
on 05/19/26
189.21 -6.36%
on 06/09/26
+13.31 (+8.12%)
since 05/18/26
3-Month
160.93 +10.09%
on 05/15/26
200.50 -11.64%
on 04/21/26
-14.33 (-7.48%)
since 03/18/26
52-Week
160.93 +10.09%
on 05/15/26
242.80 -27.03%
on 01/22/26
-17.27 (-8.88%)
since 06/18/25

Most Recent Stories

More News
Is Revvity Stock Underperforming the Nasdaq?

Revvity has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

$NASX : 26,517.93 (unch)
RVTY : 100.00 (+2.23%)
DHR : 177.17 (-0.33%)
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

AMRC : 28.64 (+4.95%)
ALIT : 0.5692 (-4.40%)
DHR : 177.17 (-0.33%)
3 Reasons to Avoid DHR and 1 Stock to Buy Instead

3 Reasons to Avoid DHR and 1 Stock to Buy Instead

DHR : 177.17 (-0.33%)
Danaher Completes Acquisition of Masimo Corporation

WASHINGTON , June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation,...

DHR : 177.17 (-0.33%)
Sirius XM Holdings Set to Join S&P MidCap 400

NEW YORK , June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday,...

MASI : 179.95 (+0.01%)
SPGI : 410.92 (-1.70%)
SIRI : 28.03 (+0.36%)
DHR : 177.17 (-0.33%)
SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations

At ASMS, SCIEX , a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new...

DHR : 177.17 (-0.33%)
SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools

At ASMS, SCIEX , a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for...

DHR : 177.17 (-0.33%)
Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

$SPX : 7,500.58 (unch)
TMO : 464.61 (+0.63%)
DHR : 177.17 (-0.33%)
Is Danaher Stock Underperforming the S&P 500?

Danaher has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 7,500.58 (unch)
DHR : 177.17 (-0.33%)
RVTY : 100.00 (+2.23%)
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William...

HSIC : 79.92 (-0.06%)
NVST : 25.91 (+4.22%)
DHR : 177.17 (-0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of...

See More

Key Turning Points

3rd Resistance Point 183.34
2nd Resistance Point 180.93
1st Resistance Point 179.05
Last Price 177.17
1st Support Level 174.75
2nd Support Level 172.34
3rd Support Level 170.46

See More

52-Week High 242.80
Fibonacci 61.8% 211.53
Fibonacci 50% 201.86
Fibonacci 38.2% 192.20
Last Price 177.17
52-Week Low 160.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.